LP-310 Treatment Demonstrates Clinically Meaningful Reductions in Pain, Ulceration, and Inflammation Across All Key Metrics Findings Highlight Favorable Safety Profile and Tolerability of Twice-Daily Oral Rinse Multicenter Phase 2a Trial Advancing to Higher Treatment Dose with Recruitment Expected to Conclude the First Half of 2025 Lipella Leadership to Present Findings at BIO CEO & Investor … Continue reading “Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus”
Breaking News
Oncocyte Prices $29.1 Million Equity Offering
Proceeds Expected to Fund Transplant Assay Through FDA IVD Clearance and Commercial Launch Strategic Partner…
Paradigm Oil and Gas Partners with Hallmark Venture Group to Drive Scalable Revenue Growth
Key Highlights: Strategic Partnership Announcement: Paradigm Oil and Gas, Inc. (OTC: PDGO) has engaged Hallmark Venture Group,…
Catheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations Strategy
BRIDGEWATER, NJ, February 10, 2025 – PRISM MediaWire – Catheter Precision Inc. (NYSE American: VTAK)…
Auddia Announces Continued Favorable 30-day Retention and the Launch of Commercial Subscriptions
faidr 30-day retention continues to build Upgraded subscription conversion optimization platform launched last week Subscription…
Day Three of IBC Suriname 2025 Concludes with a Strong Focus on Finance, Investment, and Innovation
Key Points Finance, Investment, and Economic Growth Private-Sector Investment: Keynote by Ms. Elizabeth Robberechts emphasized…
Day Two of IBC Suriname 2025 Focuses on Investment, Infrastructure, and Business Culture
Key Points: Investment & Economic Growth Investment Leadership: Keynote address emphasized integrated approaches to attract…
AmpliTech Group’s 5G Division Receives Initial Order For Three Configurations Of The Company’s Suite of 5G ORAN Radios
Hauppauge, NY, February 6, 2025 – PRISM MediaWire – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW),…
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption
WEWAHITCHKA-PORT ST JOE, FL, February 6, 2025 – PRISM MediaWire – UAV Corp. (OTC: UMAV),…
Aclarion Announces Northwestern Medicine as First CLARITY Trial Site
Northwestern Medicine is a global leader in clinical trial research, including spine CLARITY is a…
Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus
PITTSBURGH, February 6, 2025 – PRISM MediaWire – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or…
Unlocking Suriname 2025: International Business Conference Launches with High-Level Engagements and Strategic Partnerships
Paramaribo, Suriname, February 5, 2025 – PRISM MediaWire – The highly anticipated International Business Conference…
Descubra las últimas innovaciones en Desalinización América Latina 2025
Descubra las últimas innovaciones en Desalinización América Latina 2025 – el registro ya está abierto…
Discover the latest desalination innovations at Desalination Latin America 2025
Discover the latest desalination innovations at Desalination Latin America 2025 – registration is already open…
